Lynne Powell's Insider Trades & SAST Disclosures

Lynne Powell's most recent trade in Biora Therapeutics Inc was a trade of 12,500 Common Stock done . Disclosure was reported to the exchange on June 5, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 12,500 30,746 - 0 Common Stock
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (Right to Buy)
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 18,246 - 0 Common Stock
Biora Therapeutics Inc
Lynne Powell Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Jan 2023 45 0 - - Series X Preferred Stock
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 148,810 148,810 - - Stock Option (Right to Buy)
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2022 96,154 143,672 - 0 Common Stock
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 51,724 51,724 - - Stock Option (Right to Buy)
Biora Therapeutics Inc
Lynne Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2021 29,183 47,518 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades